159 related articles for article (PubMed ID: 38314298)
1. A pan-cancer analysis of the prognosis and immune infiltration of eEF1A2 and its potential function in thyroid carcinoma.
Ma N; Zhou T; Li C; Luo X; Chen S; Zhu XY; Chen XH; Liu H; Tian HY; Gao QJ; Zhao DW
Heliyon; 2024 Feb; 10(3):e24455. PubMed ID: 38314298
[TBL] [Abstract][Full Text] [Related]
2. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
3. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
[TBL] [Abstract][Full Text] [Related]
4. A pan-cancer characterization of immune-related NFIL3 identifies potential predictive biomarker.
Fei Q; Zhang X; Wang S; Shu G; Yin G
J Cancer; 2024; 15(5):1271-1286. PubMed ID: 38356719
[No Abstract] [Full Text] [Related]
5. ARPC2: A Pan-Cancer Prognostic and Immunological Biomarker That Promotes Hepatocellular Carcinoma Cell Proliferation and Invasion.
Huang S; Dong C; Li D; Xu Y; Wu J
Front Cell Dev Biol; 2022; 10():896080. PubMed ID: 35733852
[No Abstract] [Full Text] [Related]
6. A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma.
Huang S; Sun L; Hou P; Liu K; Wu J
Front Immunol; 2022; 13():944898. PubMed ID: 36148220
[TBL] [Abstract][Full Text] [Related]
7. Identification of m6A-associated LncRNAs as predict factors for the immune infiltration and prognosis of thyroid cancer.
Su Y; Xu B; Li J; Shen Q; Lei Z; Ma M; Zhang F; Hu T
Ann Med; 2023 Dec; 55(1):1298-1316. PubMed ID: 36974635
[TBL] [Abstract][Full Text] [Related]
8. Effect of activation of the Akt/mTOR signaling pathway by EEF1A2 on the biological behavior of osteosarcoma.
Yang J; Tang J; Li J; Cen Y; Chen J; Dai G
Ann Transl Med; 2021 Jan; 9(2):158. PubMed ID: 33569460
[TBL] [Abstract][Full Text] [Related]
9. The Prognostic Value and Potential Immune Mechanisms of lncRNAs Related to Immunogenic Cell Death in Papillary Thyroid Carcinoma.
Wang Y; Li X; Huang Y; Gang Q; Liu M; Zhang H; Shen S; Qi Y; Zhang J
J Inflamm Res; 2024; 17():1995-2008. PubMed ID: 38566983
[TBL] [Abstract][Full Text] [Related]
10. A Pan-Cancer Analysis of the Oncogenic Role of
Yang D; Li H; Chen Y; Li C; Ren W; Huang Y
Front Genet; 2022; 13():906174. PubMed ID: 35910232
[No Abstract] [Full Text] [Related]
11. Potential role of LPAR5 gene in prognosis and immunity of thyroid papillary carcinoma and pan-cancer.
Zhang B; Zhang L; Qi P; Pang R; Wang Z; Liu X; Shi Q; Zhang Q
Sci Rep; 2023 Apr; 13(1):5850. PubMed ID: 37037831
[TBL] [Abstract][Full Text] [Related]
12. LncRNA RGMB-AS1 is activated by E2F1 and promotes cell proliferation and invasion in papillary thyroid carcinoma.
Zhang Z; Li SY; Zhang LB
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1979-1986. PubMed ID: 29687852
[TBL] [Abstract][Full Text] [Related]
13. Eukaryotic Elongation Factor 1Alpha-2 (EEF1A2) Participates in the Progression of Gastric Cancer via Interaction with Heat Shock Protein B8 (HSPB8).
Li J; Tang X; Zhang Z
Ann Clin Lab Sci; 2023 May; 53(3):398-408. PubMed ID: 37437931
[TBL] [Abstract][Full Text] [Related]
14. Pan-cancer analyses of clinical prognosis, immune infiltration, and immunotherapy efficacy for TRPV family using multi-omics data.
Shen C; Fu C; Suo Y; Li K; Zhang Z; Yang S; Zhang Y; Lin Y; Li Z; Wu Z; Huang S; Chen H; Fan Z; Hu H
Heliyon; 2023 Jun; 9(6):e16897. PubMed ID: 37346342
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of miR-421 predicts poor prognosis and promotes proliferation, migration, and invasion of papillary thyroid cancer cells.
Dong A; Zhang J; Sun W; Hua H; Sun Y
J Chin Med Assoc; 2020 Nov; 83(11):991-996. PubMed ID: 32881717
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance and oncogenic function of NR1H4 in clear cell renal cell carcinoma.
Huang S; Hou Y; Hu M; Hu J; Liu X
BMC Cancer; 2022 Sep; 22(1):995. PubMed ID: 36123627
[TBL] [Abstract][Full Text] [Related]
17. Papillary thyroid carcinoma with a high tumor mutation burden has a poor prognosis.
Xie Z; Li X; Lun Y; He Y; Wu S; Wang S; Sun J; He Y; Xin S; Zhang J
Int Immunopharmacol; 2020 Dec; 89(Pt B):107090. PubMed ID: 33091816
[TBL] [Abstract][Full Text] [Related]
18. Multi-omics analysis of the oncogenic value of copper Metabolism-Related protein COMMD2 in human cancers.
Tai P; Wang Z; Chen X; Chen A; Gong L; Cheng Y; Cao K
Cancer Med; 2023 May; 12(10):11941-11959. PubMed ID: 36205192
[TBL] [Abstract][Full Text] [Related]
19. Depletion of VAX2 Restrains the Malignant Progression of Papillary Thyroid Carcinoma by Modulating ERK Signaling Pathway.
Guo B; Zhang Y; Yuan K; Jiang FX; Cui QB; Zhou Q; Dong HX; Chen W; Yang SS
Open Life Sci; 2019 Jan; 14():237-245. PubMed ID: 33817157
[TBL] [Abstract][Full Text] [Related]
20. Pan-cancer Multi-omics Analysis Reveals HMGN1 as a Potential Prognostic and Immune Infiltration-associated Biomarker.
Guo Y; Zhang R; Xu H; Hong K; Cen K; Mai Y; Wu Z
Curr Med Chem; 2024 Jan; ():. PubMed ID: 38310387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
